John L Mcmanus - Net Worth and Insider Trading

John L Mcmanus Net Worth

The estimated net worth of John L Mcmanus is at least $8 dollars as of 2024-05-27. John L Mcmanus is the President and CEO of Aeolus Pharmaceuticals Inc and owns about 80,300 shares of Aeolus Pharmaceuticals Inc (AOLS) stock worth over $8. Details can be seen in John L Mcmanus's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John L Mcmanus has not made any transactions after 2013-03-06 and currently still holds the listed stock(s).

Transaction Summary of John L Mcmanus

To

John L Mcmanus Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John L Mcmanus owns 2 companies in total, including Aeolus Pharmaceuticals Inc (AOLS) , and Spectrum Pharmaceuticals Inc (SPPI) .

Click here to see the complete history of John L Mcmanus’s form 4 insider trades.

Insider Ownership Summary of John L Mcmanus

Ticker Comapny Transaction Date Type of Owner
AOLS Aeolus Pharmaceuticals Inc 2016-03-04 President and CEO
SPPI Spectrum Pharmaceuticals Inc 2003-09-12 VP,Finance & Strategic Planning

John L Mcmanus Latest Holdings Summary

John L Mcmanus currently owns a total of 1 stock. John L Mcmanus owns 80,300 shares of Aeolus Pharmaceuticals Inc (AOLS) as of March 6, 2013, with a value of $8.

Latest Holdings of John L Mcmanus

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AOLS Aeolus Pharmaceuticals Inc 2013-03-06 80,300 0.00 8

Holding Weightings of John L Mcmanus


John L Mcmanus Form 4 Trading Tracker

According to the SEC Form 4 filings, John L Mcmanus has made a total of 0 transactions in Aeolus Pharmaceuticals Inc (AOLS) over the past 5 years. The most-recent trade in Aeolus Pharmaceuticals Inc is the acquisition of 10,000 shares on March 6, 2013, which cost John L Mcmanus around $3,500.

Insider Trading History of John L Mcmanus

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John L Mcmanus Trading Performance

GuruFocus tracks the stock performance after each of John L Mcmanus's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John L Mcmanus is -9.36%. GuruFocus also compares John L Mcmanus's trading performance to market benchmark return within the same time period. The performance of stocks bought by John L Mcmanus within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John L Mcmanus's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John L Mcmanus

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.73
Relative Return to S&P 500(%) -7.78

John L Mcmanus Ownership Network

Ownership Network List of John L Mcmanus

No Data

Ownership Network Relation of John L Mcmanus


John L Mcmanus Owned Company Details

What does Aeolus Pharmaceuticals Inc do?

Who are the key executives at Aeolus Pharmaceuticals Inc?

John L Mcmanus is the President and CEO of Aeolus Pharmaceuticals Inc. Other key executives at Aeolus Pharmaceuticals Inc include Chief Financial Officer Russell Skibsted , 10 percent owner Mark Lappe , and 10 percent owner & other: Indirect Beneficial Owner Biotechnology Value Fund L P .

Aeolus Pharmaceuticals Inc (AOLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aeolus Pharmaceuticals Inc (AOLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeolus Pharmaceuticals Inc (AOLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aeolus Pharmaceuticals Inc (AOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aeolus Pharmaceuticals Inc Insider Transactions

No Available Data

John L Mcmanus Mailing Address

Above is the net worth, insider trading, and ownership report for John L Mcmanus. You might contact John L Mcmanus via mailing address: C/o Aeolus Pharmaceuticals, Inc., 26361 Crown Valley Parkway, Suite 150, Mission Viejo Ca 92691.

Discussions on John L Mcmanus

No discussions yet.